↓ Skip to main content

Long‐acting beta2‐agonists for chronic obstructive pulmonary disease

Overview of attention for article published in Cochrane database of systematic reviews, October 2013
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

news
1 news outlet
blogs
2 blogs
twitter
34 tweeters
facebook
1 Facebook page
googleplus
2 Google+ users

Citations

dimensions_citation
56 Dimensions

Readers on

mendeley
23 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Long‐acting beta2‐agonists for chronic obstructive pulmonary disease
Published in
Cochrane database of systematic reviews, October 2013
DOI 10.1002/14651858.cd010177.pub2
Pubmed ID
Authors

Kew KM, Mavergames C, Walters JA, Kayleigh M Kew, Chris Mavergames, Julia AE Walters, Kew, Kayleigh M, Mavergames, Chris, Walters, Julia AE

Abstract

Chronic obstructive pulmonary disease (COPD) is a respiratory disease that causes progressive symptoms of breathlessness, cough and mucus build-up. It is the fourth or fifth most common cause of death worldwide and is associated with significant healthcare costs.Inhaled long-acting beta2-agonists (LABAs) are widely prescribed to manage the symptoms of COPD when short-acting agents alone are no longer sufficient. Twice-daily treatment with an inhaled LABA is aimed at relieving symptoms, improving exercise tolerance and quality of life, slowing decline and even improving lung function and preventing and treating exacerbations.

Twitter Demographics

The data shown below were collected from the profiles of 34 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 23 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 23 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 5 22%
Unspecified 4 17%
Professor 3 13%
Student > Ph. D. Student 3 13%
Researcher 3 13%
Other 5 22%
Readers by discipline Count As %
Medicine and Dentistry 8 35%
Unspecified 4 17%
Biochemistry, Genetics and Molecular Biology 2 9%
Nursing and Health Professions 2 9%
Psychology 2 9%
Other 5 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 43. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 November 2016.
All research outputs
#282,311
of 11,342,664 outputs
Outputs from Cochrane database of systematic reviews
#945
of 9,068 outputs
Outputs of similar age
#4,687
of 153,757 outputs
Outputs of similar age from Cochrane database of systematic reviews
#11
of 101 outputs
Altmetric has tracked 11,342,664 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 9,068 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.2. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 153,757 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 101 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.